| pubmed-article:17547461 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17547461 | lifeskim:mentions | umls-concept:C0025664 | lld:lifeskim |
| pubmed-article:17547461 | lifeskim:mentions | umls-concept:C1956076 | lld:lifeskim |
| pubmed-article:17547461 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:17547461 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:17547461 | lifeskim:mentions | umls-concept:C1553039 | lld:lifeskim |
| pubmed-article:17547461 | pubmed:issue | 14 | lld:pubmed |
| pubmed-article:17547461 | pubmed:dateCreated | 2007-6-29 | lld:pubmed |
| pubmed-article:17547461 | pubmed:abstractText | An enantioselective two-step route to substituted benzo[a]- and indolo[2,3-a]quinolizidines has been developed. It consists of (i) a stereoselective cyclocondensation of a racemic or prochiral delta-oxo(di)ester with either (S)-(3,4-dimethoxyphenyl)alaninol or (S)-tryptophanol in a process involving a dynamic kinetic resolution and/or the differentiation of enantiotopic or diastereotopic ester groups, and (ii) a subsequent stereocontrolled cyclization on the aromatic ring taking advantage of the masked N-acyl iminium ion present in the resulting oxazolopiperidone lactams. | lld:pubmed |
| pubmed-article:17547461 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17547461 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17547461 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17547461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17547461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17547461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17547461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17547461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17547461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17547461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17547461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17547461 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17547461 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:17547461 | pubmed:issn | 0022-3263 | lld:pubmed |
| pubmed-article:17547461 | pubmed:author | pubmed-author:MolinsEliesE | lld:pubmed |
| pubmed-article:17547461 | pubmed:author | pubmed-author:EscolanoCarme... | lld:pubmed |
| pubmed-article:17547461 | pubmed:author | pubmed-author:AmatMercedesM | lld:pubmed |
| pubmed-article:17547461 | pubmed:author | pubmed-author:LlorNúriaN | lld:pubmed |
| pubmed-article:17547461 | pubmed:author | pubmed-author:BoschJoanJ | lld:pubmed |
| pubmed-article:17547461 | pubmed:author | pubmed-author:McKeeVickieV | lld:pubmed |
| pubmed-article:17547461 | pubmed:author | pubmed-author:AllinSteven... | lld:pubmed |
| pubmed-article:17547461 | pubmed:author | pubmed-author:BassasOriolO | lld:pubmed |
| pubmed-article:17547461 | pubmed:author | pubmed-author:SantosMaria... | lld:pubmed |
| pubmed-article:17547461 | pubmed:author | pubmed-author:Gómez-EsquéAr... | lld:pubmed |
| pubmed-article:17547461 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17547461 | pubmed:day | 6 | lld:pubmed |
| pubmed-article:17547461 | pubmed:volume | 72 | lld:pubmed |
| pubmed-article:17547461 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17547461 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17547461 | pubmed:pagination | 5193-201 | lld:pubmed |
| pubmed-article:17547461 | pubmed:meshHeading | pubmed-meshheading:17547461... | lld:pubmed |
| pubmed-article:17547461 | pubmed:meshHeading | pubmed-meshheading:17547461... | lld:pubmed |
| pubmed-article:17547461 | pubmed:meshHeading | pubmed-meshheading:17547461... | lld:pubmed |
| pubmed-article:17547461 | pubmed:meshHeading | pubmed-meshheading:17547461... | lld:pubmed |
| pubmed-article:17547461 | pubmed:meshHeading | pubmed-meshheading:17547461... | lld:pubmed |
| pubmed-article:17547461 | pubmed:meshHeading | pubmed-meshheading:17547461... | lld:pubmed |
| pubmed-article:17547461 | pubmed:meshHeading | pubmed-meshheading:17547461... | lld:pubmed |
| pubmed-article:17547461 | pubmed:meshHeading | pubmed-meshheading:17547461... | lld:pubmed |
| pubmed-article:17547461 | pubmed:meshHeading | pubmed-meshheading:17547461... | lld:pubmed |
| pubmed-article:17547461 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17547461 | pubmed:articleTitle | Straightforward methodology for the enantioselective synthesis of benzo[a]- and indolo[2,3-a]quinolizidines. | lld:pubmed |
| pubmed-article:17547461 | pubmed:affiliation | Laboratory of Organic Chemistry, Faculty of Pharmacy, University of Barcelona, 08028-Barcelona, Spain. amat@ub.edu | lld:pubmed |
| pubmed-article:17547461 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17547461 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
